WHWK Latest Press Releases

-- October 1, 2026 --

Whitehawk Therapeutics Presents Real-World Analyses Supporting MUC16 as a Durable ADC Target in Ovarian Cancer at IGCS 2026 PRNewswire 8:01 AM

-- September 13, 2026 --

Whitehawk Therapeutics Presents Real-World Analyses Supporting PTK7 as a Durable ADC Target in EGFR Wild-Type Non-Small Cell Lung Cancer at WCLC 2026 PRNewswire 9:30 PM

-- September 10, 2026 --

Whitehawk Therapeutics Appoints Vijay Iyengar, MD, to Board of Directors PRNewswire 4:05 PM

-- September 2, 2026 --

Whitehawk Therapeutics to Participate in Upcoming Investor Conferences PRNewswire 8:01 AM

-- August 6, 2026 --

Whitehawk Therapeutics Reports Second Quarter 2026 Financial Results and Recent Highlights PRNewswire 8:00 AM

-- July 7, 2026 --

Biocytogen and Whitehawk Therapeutics Enter Global Collaboration for Bispecific Antibody ADC Development Business Wire 8:00 AM

-- May 30, 2026 --

Whitehawk Therapeutics Presents Real-World Analysis Confirming SEZ6 as a Highly Expressed, Clinically Relevant Target for SCLC and Other Neuroendocrine Tumors at ASCO 2026 PRNewswire 2:30 PM

Market Data Delayed 15 Minutes